Cargando…

The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer

OBJECTIVE: Bladder-preserving trimodal therapy is recognized as a promising alternative treatment for muscle-invasive bladder cancer. We report the updated outcomes of muscle-invasive bladder cancer patients that were treated using our treatment protocol, which involves radiotherapy delivered with a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyata, Haruka, Osawa, Takahiro, Abe, Takashige, Kikuchi, Hiroshi, Matsumoto, Ryuji, Maruyama, Satoru, Nishioka, Kentaro, Shimizu, Shinichi, Hashimoto, Takayuki, Shirato, Hiroki, Shinohara, Nobuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202139/ https://www.ncbi.nlm.nih.gov/pubmed/31955206 http://dx.doi.org/10.1093/jjco/hyz211

Ejemplares similares

Quality improvement in managing patients with non-muscle-invasive bladder cancer by introducing a surgical checklist for transurethral resection of bladder tumor
por: Kikuchi, Hiroshi, et al.
Publicado: (2022)

Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers
por: Nishioka, Kentaro, et al.
Publicado: (2017)

Outcomes of bacillus Calmette–Guérin therapy without a maintenance schedule for high‐risk non‐muscle‐invasive bladder cancer in the second transurethral resection era
por: Kikuchi, Hiroshi, et al.
Publicado: (2021)

Are simple verbal instructions sufficient to ensure that bladder volume does not deteriorate prostate position reproducibility during spot scanning proton therapy?
por: Nishioka, Kentaro, et al.
Publicado: (2021)

Prospective Phase II Study of Image-guided Local Boost Using a Real-time Tumor-tracking Radiotherapy (RTRT) System for Locally Advanced Bladder Cancer
por: Nishioka, Kentaro, et al.
Publicado: (2014)

The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapy
por: Dekura, Yasuhiro, et al.
Publicado: (2019)

Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer
por: Shinohara, Nobuo, et al.
Publicado: (2013)

Early results of urethral dose reduction and small safety margin in intensity-modulated radiation therapy (IMRT) for localized prostate cancer using a real-time tumor-tracking radiotherapy (RTRT) system
por: Shimizu, Shinichi, et al.
Publicado: (2014)

Trimodality Therapy for Bladder Preservation in the Elderly Population with Invasive Bladder Cancer
por: Turgeon, Guy-Anne, et al.
Publicado: (2014)

Perioperative morbidity and mortality of octogenarians treated by radical cystectomy—a multi-institutional retrospective study in Japan
por: Abe, Takashige, et al.
Publicado: (2017)

Validity assessment of the laparoscopic radical nephrectomy module of the LapVision virtual reality simulator
por: Miyata, Haruka, et al.
Publicado: (2019)

Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
por: Joung, Jae Young, et al.
Publicado: (2008)

Primary renal leiomyosarcoma with a tumor thrombus in the inferior vena cava
por: Konno, Mikio, et al.
Publicado: (2021)

Validation of the Japanese version of the Body Image Scale for bladder cancer patients
por: Sato, Miho, et al.
Publicado: (2022)

Impact of postoperative complications on long-term survival in bladder cancer patients
por: Abe, Takashige, et al.
Publicado: (2023)

Comparison between standard and reduced volume radiotherapy in bladder preservation trimodality protocol for muscle-invasive bladder cancer patients
por: Arafat, Waleed, et al.
Publicado: (2016)

Endoclips as novel fiducial markers in trimodality bladder-preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes
por: Shahbaz, Muhammad, et al.
Publicado: (2020)

Role of surgical consolidation in metastatic urothelial carcinoma
por: Abe, Takashige, et al.
Publicado: (2016)

Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index
por: Osawa, Takahiro, et al.
Publicado: (2020)

Validation of an online application to identify potential immune-related adverse events associated with immune checkpoint inhibitors based on the patient’s symptoms
por: Osawa, Takahiro, et al.
Publicado: (2022)

Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells
por: Matsumoto, Ryuji, et al.
Publicado: (2016)

Editorial Comment: Endoclips as novel fiducial markers in trimodality bladder preserving therapy of muscle-invasive bladder carcinoma: feasibility and patient outcomes
por: dos Reis, Rodolfo Borges, et al.
Publicado: (2020)

Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan
por: Matsumoto, Ryuji, et al.
Publicado: (2018)

Concurrent occurrence of renal cell carcinoma with rhabdoid features in a married couple: a case report
por: Matsumoto, Ryuji, et al.
Publicado: (2015)

Comparative study of lymph node dissection, and oncological outcomes of laparoscopic and open radical nephroureterectomy for patients with urothelial carcinoma of the upper urinary tract undergoing regional lymph node dissection
por: Abe, Takashige, et al.
Publicado: (2018)

Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience
por: Polineni, Praneet, et al.
Publicado: (2021)

Postoperative thyroid storm after radical nephrectomy for renal cell carcinoma with inferior vena cava tumor thrombus
por: Iwahara, Naoya, et al.
Publicado: (2021)

Favorable response to pembrolizumab in granulocyte colony‐stimulating factor‐producing upper urinary tract urothelial carcinoma
por: Takeda, Hiroki, et al.
Publicado: (2021)

Metastatic neuroendocrine carcinoma of right adrenal gland successfully treated with laparoscopic adrenalectomy after multimodal therapy
por: Yamagata, Yusuke, et al.
Publicado: (2022)

Erratum: Prognostic impact of local radiotherapy on metastatic urothelial carcinoma patients receiving systemic chemotherapy
por: Abe, Takashige, et al.
Publicado: (2020)

Evaluation of inter-observer variability of bladder boundary delineation on cone-beam CT
por: Nishioka, Kentaro, et al.
Publicado: (2013)

Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis
por: Su, Xiaozhe, et al.
Publicado: (2023)

The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016)

Adaptor protein CRK induces epithelial–mesenchymal transition and metastasis of bladder cancer cells through HGF/c-Met feedback loop
por: Matsumoto, Ryuji, et al.
Publicado: (2015)

Trimodal Therapy Using an MR–guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder Cancer
por: Liveringhouse, Casey, et al.
Publicado: (2023)

Five-point Likert scaling on MRI predicts clinically significant prostate carcinoma
por: Harada, Taisuke, et al.
Publicado: (2015)

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
por: Kumar, Abhishek, et al.
Publicado: (2021)

Development and validation of a porcine organ model for training in essential laparoscopic surgical skills
por: Higuchi, Madoka, et al.
Publicado: (2020)

Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis
por: Ding, Hui, et al.
Publicado: (2020)

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer
por: Guo, Yadong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eoggtrrdf1gov3icrkree68k1l